Should We Extend the Use of Oral Antibiotics in Infective Endocarditis? The ENDO-ORAL Study
Oral switch is a suitable option beyond "classical" frontiers in the management of IE, with potential direct and indirect benefits.
Authors
- Maxime Hentzien (ORCID: https://orcid.org/0000-0003-2729-9420)
- Mathieu Blot (ORCID: https://orcid.org/0000-0001-6541-2434)
- Romane Pouy
- Claire Coutureau (ORCID: https://orcid.org/0000-0002-1035-0237)
- Lionel Piroth (ORCID: https://orcid.org/0000-0003-4478-1032)
- Thibault Sixt (ORCID: https://orcid.org/0000-0002-2966-6346)
- Firouzé Bani‐Sadr (ORCID: https://orcid.org/0000-0001-8268-866X)
- Marin Moutel
- Benoit Rallet (ORCID: https://orcid.org/0009-0007-6671-6342)
Institutions
- Université de Bourgogne (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- CHU Dijon Bourgogne (FR)
- Maison des Sciences sociales et des Humanités de Dijon (FR)
- Université Bourgogne Europe (FR)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1093/cid/ciaf452
- Citations
- 2
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.71